Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. [PDF]
, 2020 BackgroundEarly pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg,
Atrio, Jessica M +6 more
core +1 more source
Attenuation of ischemic liver injury by prostaglandin E
, 1998 Background: Prostaglandin has been reported to have protective effects against liver injury. Use of this agent in clinical settings, however, is limited because of drugrelated side effects.
Ishizaki, N +8 more
core +1 more source
Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastropathy in Patients With Chronic Arthritis? [PDF]
, 1994 Whether misoprostol, a synthetic prostaglandin E1 analogue, should be routinely prescribed along with nonsteriodal anti-inflammatory drugs (NSAIDS) to prevent gastric damage is of great clinical importance and has profound cost implications. No consensus
Johannesson, Magnus +2 more
core +1 more source
Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention. [PDF]
, 2014 BackgroundBangladesh is one of the few countries that may actually achieve the fifth Millennium Development Goal (MDG) in time, despite skilled birth attendance remaining low.
Bell, Suzanne +2 more
core +1 more source
Comprehensive abortion care: evidence of improvements in hospital-level indicators in Tigray, Ethiopia. [PDF]
, 2013 ObjectiveApproximately 18% of maternal deaths in East Africa is attributable to unsafe abortion. Availability of comprehensive abortion care (CAC) services at all levels of the healthcare system, including medical abortion, has the potential to increase ...
Bell, Suzanne +2 more
core +2 more sources
BMC Pregnancy and Childbirth, 2022 Background Various methods are used for cervical ripening during the induction of labor. Mechanical and pharmacological methods are commonly used for cervical ripening.
Ge Zhao, Guang Song, Jing Liu
doaj +1 more source
Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report
Novelty in Biomedicine, 2022 Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj +1 more source
Recent advances: rheumatology [PDF]
, 2000 No abstract ...
Madhok, R., Kerr, H., Capell, H.A.
core +6 more sources
Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis
Scientific Reports, 2017 The efficacy and safety of misoprostol alone for missed abortion varied with different regimens. To evaluate existing evidence for the medical management of missed abortion using misoprostol, we undertook a comprehensive review and meta-analysis.
Hang-lin Wu +4 more
doaj +1 more source
A comparative study between isosorbide mononitrate (IMN) versus misoprostol prior to hysteroscopy
Middle East Fertility Society Journal, 2010 Objective: To compare the efficacy of a nitric oxide donor (isosorbide mononitrate) and a prostaglandin E1 analogue (misoprostol) for cervical priming before hysteroscopy. Design: Comparative clinical trial.
Waleed El-Khayat +2 more
doaj +1 more source